Sign In

Tanya Liu

Professional Background

Tanya Liu is a highly accomplished professional in the field of health economics and market access, currently serving as the Director of US Value & Access for Dupixent at Sanofi Genzyme. With a robust foundation in healthcare strategy and economic evaluation, Tanya has dedicated her career to ensuring that patients have access to innovative therapies. She has leveraged her expertise to impact the lives of many individuals grappling with chronic conditions, particularly those requiring targeted treatments like Dupixent.

Before her current role, Tanya held the position of Associate Director for Global Value & Access of Dupixent at Sanofi Genzyme where she played a critical role in shaping the drug’s market strategy on an international scale. Her strategic insights and leadership abilities have been pivotal in navigating the complexities of healthcare systems and insurance approvals.

Tanya's career also includes valuable experiences outside of Sanofi. She contributed her analytical skills as a Manager at Simon-Kucher & Partners, where she focused on pricing strategies and market access solutions for pharmaceutical clients. Prior to that, she gained insights into the healthcare consultancy landscape as a Senior Associate Intern at PwC, helping various businesses streamline their operations and evaluate market feasibility for their products.

Tanya's impressive journey began during her academic career, where she took on research roles that enhanced her understanding of biomedical innovations. As a Research Assistant at the NEWDIGS initiative within MIT's Center for Biomedical Innovation, she engaged with projects aimed at reforming how innovative medicines are developed and valued. Her formative years at UCLA as a Research Associate further solidified her dedication to advancing healthcare through research and strategic thinking.

Education and Achievements

Tanya Liu's educational background is marked by prestigious institutions and rigorous training. She earned her Master of Science (M.S.) degree from the Massachusetts Institute of Technology (MIT), where she honed her analytical and problem-solving skills that are essential in the field of healthcare economics. Her rigorous academic training laid the groundwork for her successful career in market access and health policy.

Prior to MIT, Tanya completed her undergraduate studies with a Bachelor's degree from Pomona College, where she developed a strong foundation in liberal arts, critical thinking, and research methodologies. Additionally, she has international exposure from her studies at the University of Melbourne, which provided her with a unique perspective on global healthcare systems and policy. This diverse educational background empowers Tanya to approach complex challenges in healthcare from multiple angles, making her a well-rounded professional in her field.

Tanya has not only excelled academically but has also achieved significant milestones in her career. Her influence in the healthcare sector, especially concerning Dupixent, demonstrates her ability to translate scientific knowledge into impactful healthcare initiatives. As she continues to thrive at Sanofi Genzyme, her contributions are expected to shape the future of healthcare access for many patients.

Achievements

  • Director of US Value & Access at Sanofi Genzyme: In this current capacity, Tanya Liu is responsible for ensuring patient access to Dupixent, navigating the complex landscape of insurance, healthcare policies, and market dynamics. Her leadership and strategic direction are crucial in the launch and continued success of this groundbreaking treatment.

  • Associate Director for Global Value & Access at Sanofi Genzyme: Tanya played a vital role in developing global strategies for market access, working collaboratively with cross-functional teams to ensure the integration of economic evidence into decision-making processes.

  • Manager at Simon-Kucher & Partners: Here, Tanya demonstrated her expertise in market access consulting by devising strategic pricing and access solutions for pharmaceutical clients, which has had lasting effects on the market viability of various health innovations.

  • Research Contributions at MIT and UCLA: Tanya's early research experiences at MIT’s NEWDIGS initiative and UCLA have culminated in contributions to advancing biomedical innovation frameworks. These positions not only honed her research capabilities but also ignited her passion for establishing better access to pharmaceuticals through informed economic analysis.

Throughout her career, Tanya Liu has shown dedication, expertise, and a commitment to improving healthcare access and outcomes. As a leader in her field, she continues to be a powerful advocate for patients, ensuring that innovative therapies are not just developed but are also accessible to the people who need them most.

Related Questions

How did Tanya Liu become a leader in health economics and market access?
What key insights did Tanya Liu gain during her education at MIT?
How has Tanya Liu's experience at Simon-Kucher & Partners influenced her current role at Sanofi Genzyme?
In what ways did Tanya Liu's role at NEWDIGS contribute to her expertise in biomedical innovation?
What strategies does Tanya Liu employ to ensure patient access to Dupixent?
Tanya Liu
Add to my network

Location

Cambridge, Massachusetts, United States